AI/ML platforms</a>&nbsp;can improve outcomes, support label expansions and payer support, and help them establish a competitive advantage in a crowded marketplace. </p>" /> AI/ML platforms</a>&nbsp;can improve outcomes, support label expansions and payer support, and help them establish a competitive advantage in a crowded marketplace. </p>" />
White Paper
Precision medicine in the real world: A strategic AI/ML approach to identify & segment sub-populations
How an AI driven platform helps rapidly determine which sub-populations are likely to respond positively to a treatment or vaccine.
Oct 27, 2020

Demand for targeted precision medicines and the pressure to develop vaccines in record time are two important and intertwined trends – but they both face the same challenge: proving these products will be safe and effective for patients in the real world based on limited clinical data. This paper explores the unique challenges that pharma companies face in bringing these treatments and vaccines to market, and how using AI/ML platforms can improve outcomes, support label expansions and payer support, and help them establish a competitive advantage in a crowded marketplace.

Related solutions

Contact Us